The School of Clinical Medicine, Fujian Medical University, Fuzhou, Fujian, China.
Clinical Medical Research Center for Gynecology and Reproductive Health of Fujian Province, Laboratory of Research and Diagnosis of Gynecological Diseases of Xiamen City, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China.
FASEB J. 2024 May 15;38(9):e23622. doi: 10.1096/fj.202302195R.
Endometriosis (EMs)-related infertility commonly has decreased endometrial receptivity and normal decidualization is the basis for establishing and maintaining endometrial receptivity. However, the potential molecular regulatory mechanisms of impaired endometrial decidualization in patients with EMs have not been fully clarified. We confirmed the existence of reduced endometrial receptivity in patients with EMs by scanning electron microscopy and quantitative real-time PCR. Here we identified an lncRNA, named BMPR1B-AS1, which is significantly downregulated in eutopic endometrium in EMs patients and plays an essential role in decidual formation. Furthermore, RNA pull-down, mass spectrometry, RNA immunoprecipitation, and rescue analyses revealed that BMPR1B-AS1 positively regulates decidual formation through interaction with the RNA-binding protein insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2). Downregulation of IGF2BP2 led to a decreased stability of BMPR1B-AS1 and inhibition of activation of the SMAD1/5/9 pathway, an inhibitory effect which diminished decidualization in human endometrial stromal cells (hESCs) decidualization. In conclusion, our identified a novel regulatory mechanism in which the IGF2BP2-BMPR1B-AS1-SMAD1/5/9 axis plays a key role in the regulation of decidualization, providing insights into the potential link between abnormal decidualization and infertility in patients with EMs, which will be of clinical significance for the management and treatment of infertility in patients with EMs.
子宫内膜异位症(EMs)相关的不孕通常表现为子宫内膜容受性降低,而正常的蜕膜化是建立和维持子宫内膜容受性的基础。然而,EMs 患者子宫内膜蜕膜化受损的潜在分子调控机制尚未完全阐明。我们通过扫描电子显微镜和实时定量 PCR 证实了 EMs 患者存在子宫内膜容受性降低。在这里,我们鉴定了一种 lncRNA,命名为 BMPR1B-AS1,它在 EMs 患者的在位子宫内膜中显著下调,在蜕膜形成中发挥重要作用。此外,RNA 下拉、质谱分析、RNA 免疫沉淀和挽救分析表明,BMPR1B-AS1 通过与 RNA 结合蛋白胰岛素样生长因子 2 mRNA 结合蛋白 2(IGF2BP2)相互作用,正向调控蜕膜形成。IGF2BP2 的下调导致 BMPR1B-AS1 的稳定性降低,并抑制 SMAD1/5/9 通路的激活,这种抑制作用减弱了人子宫内膜基质细胞(hESCs)蜕膜化中的蜕膜化。总之,我们发现了一种新的调控机制,即 IGF2BP2-BMPR1B-AS1-SMAD1/5/9 轴在蜕膜化调节中发挥关键作用,为 EMs 患者异常蜕膜化和不孕之间的潜在联系提供了新的见解,这对于 EMs 患者不孕的管理和治疗具有重要的临床意义。